Grant Chamberlain - Profile and Investment Details

Investor Profile

Grant Chamberlain is a Venture Capital, Private Equity Firm based in Sydney, New South Wales, Australia with a diverse investment portfolio that includes companies such as AdGent Digital, OVO, Prota Therapeutics, Clinical Genomics Technologies, Smart Sparrow, Zoomo, Employment Hero, Hatchtech, Find-Me Technologies Pty Ltd, Peak3, Shippit, Kira Biotech, Paragen Bio, 8i, Incoming Media, Murdoch Childrens Research Institute (MCRI), Hometime, BiVACOR, Vaxxas, Blade Therapeutics, Paloma Mobile, Beasy, Phocas, Madorra. Over time, Grant Chamberlain has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Grant Chamberlain is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Dining, Health Care, E-commerce, Delivery Service, Women Founded, Enterprise Software, HR Tech, Android, Women Led, Employment, Life Science, Hotels, Sharing Economy, Banking, Robotics, Property Management, Electric Vehicles, Information Technology (IT), Biotech, Finance, Medical Device, IT Services, Software, Manufacturing, Healthcare, Biotechnology, Employee Benefits, Logistics, Internet, Hospitality, Subscription Businesses, Travel, Medical, SaaS, Real Estate, Therapeutics, Pharmaceuticals, Shipping, Biopharma may find it worthwhile to explore potential connections with Grant Chamberlain, as their portfolio suggests a familiarity and interest in this area.

Understanding Grant Chamberlain’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.